Halt on research for late-stage study of Aflibercept:
Press release reports state that, a late-stage study of a cancer drug candidate aflibercept has been stopped, because it was not working much better than a placebo. Aflibercept is still being tested as a primary treatment for prostate cancer, and as secondary treatments for colorectal cancer and non-small cell lung cancer.
Duloxetine HCl (Cymbalta) reported to reduces chronic back pain :
Cymbalta (duloxetine HCl) reduced pain over 41 weeks for patients with chronic lower back pain, as the drugmaker again tries to gain Food and Drug Administration approval for the new use.
Avastin may shrink NF2 patients' tumors, study suggests:
Reports in the New England Journal of Medicine state that the use of Avastin (bevacizumab) to treat neurofibromatosis type 2 (NF2) and how the therapy wasn't uniformly successful" in a trial of eight patients, but tumors shrank 20 percent or more in six patients.